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ABSTRACT
With the completion of the historic Apollo 
Program, the significant medical findings will 
be reviewed and the medical results summarized. 
The medical objectives of Sky lab will be pre- 
sented. The medical experiments which will 
be conducted and their relationship to the 
Apollo medical findings and Skylab objectives 
will be discussed. The interrelationship of 
the Sky lab medical experiments will be 
described and the anticipated information to 
be obtained will be postulated.
I will briefly describe the findings associ- 
ated with each of these areas, of the hardware 
developed to support the experiments associ- 
ated, and describe the procedures and signifi- 
cance of the medical investigations associated 
with each. It is important to recognize that 
all of the findings on observed changes in 
manned space flight to date have been revers- 
ible and have returned to the preflight 
values for each individual during the post- 
flight observation period.
INTRODUCTION
Today we stand on the threshold of a new era 
in the United States Manned Space Flight 
Program. Mercury, Gemini and Apollo led the 
way by establishing unequivocably that man 
can effectively perform operational and 
applied missions in space flight. The new 
era in which we are about to embark next 
month will capitalize on all that we have 
learned and will, for the first time, empha- 
size scientific investigations rather than 
operations and applications. The Skylab Program 
has maintained throughout its design and devel- 
opment, its basic objective to provide an 
orbiting laboratory capability and my remarks 
will be devoted to the importance of this 
program to the Life Sciences. The contribu- 
tion the medical experiments will provide to 
the further understanding of some of the i 
physiological adaptative processes and mech- 
anisms involved in the observed changes in 
our manned space flights to date will be dis- 
cussed. Time will not permit covering the 
entire Life Sciences Experiments Program in 
Skylab. This paper will be limited to the 
medical experiments.
OF MAJOR MEDICAL OBSERVATIONS
As a result of the Mercury, Gemini and Apollo 
manned space flights, certain findings have 
resulted and can be described in six major 
areas of human systems (Figure l) .
METABOLISM (Figure 2)
This is more specifically referred to as 
nutritional and musculoskeletal function 
because ve are interested in the basic meta- 
bolic processes of man as they are influenced 
by the space flight environment. The most 
significant finding, to date, has been the 
consistent weight loss experienced by every 
astronaut during a mission. We have had one 
exception; Al Shepard in Apollo 1^. Most 
of the weight loss has been attributed to 
loss of body fluid although a small percent 
has been lean body mass. There has been in- 
direct evidence of either loss or shift of 
body calcium or perhaps both. Attempts to 
determine changes in bone density from pre- 
to postflight have not been consistent in 
verifying total loss of body calcium as 
opposed to the alternate theory of calcium 
shift. It may be that the manned space 
flights to date have been too short to estab- 
lish the true picture associated with calcium 
metabolism and the musculoskeletal system. 
Electrolyte changes have occurred and are 
most likely associated with the loss of body 
fluid.
An example of the difficulty in establishing 
specific and consistent findings is the 
potassium studies associated with Apollo 15 
and 16. In Apollo 15, we used K*2 which is 
a method for determining total body exchange- 
able potassium. At the postflight determina- 
tion, it was found that the two astronauts
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who had been to the lunar surface had a 15$ 
decrement from their preflight value obtained 
at F minus 5. The Command Module Pilot had a 
10$ decrement. During the interval between 
Apollo 15 and l6, changes to the diet by 
selecting foods high in potassium and forti- 
fying some of the beverages using a potassium 
supplement were instituted. In addition, 
special attention was paid to the timeline 
with emphasis on adequate rest periods and 
planning no excessive work days. The Apollo 
l6 crew showed no significant change in their 
potassium levels postflight. One cannot 
attribute this result just to the change in 
potassium intake but it certainly points up 
the relationship of the nutritional aspect in 
terms of maintaining an adequate balance of 
basic constituents associated with metabolic 
activities. Generally speaking, the changes 
observed in this area returned to preflight 
control levels from three to five days after 
recovery.
In Skylab, we plan a comprehensive controlled 
metabolic balance study which will provide 
data on the inflight status of fluid, electro- 
lyte and hormonal changes coupled with pre- 
and postflight data on skeletal and muscle 
mass changes. The Sky lab crews will commence 
this experiment 21 days preflight by going on 
the Skylab diet exclusively, to insure a 
nutritionally stabilized situation at launch. 
They will stay on this for 18 days after 
recovery while the postflight investigations 
are completed. Precise measurement of the 
nutritional constituents will be maintained 
throughout the entire period from 21 days 
preflight through 18 days postflight. All 
food and fluid intake and output will be 
measured during this entire period. Uncon- 
suraed portions of food inflight will be mea- 
sured by the Small Mass Measurement Device 
(Figure 3)  
Inflight, we will be obtaining a 120 cc 
sample of urine from each crewman each day 
from their 2k hour output. This along with 
all feces, which will be dried and returned 
with the urine, will be analyzed postflight 
(Figure k) . Daily mass measurement will be 
obtained inflight using the Whole Body Mass 
Measurement Device pictured in Figure 5. 
This inflight capability will permit the first 
indepth study of the metabolic functions 
associated with man and his activities in the 
space flight environment. It is anticipated 
that we will have a better understanding of 
fluid balance mechanisms as a function of 
time inflight with the associated electrolyte 
and hormonal data. It is anticipated that 
more definitive information on calcium, bone 
and muscle mass changes will be obtained.
PEMATOLOGT AMD IMMUNOLOGY- (Figure 6)
In Gemini and Apollo, we have measured the 
loss of red cell mass in those flights where 
oxygen partial pressures have predominated. 
In those Apollo missions which had no cabin 
decompression for EVA or where it was postu- 
lated that a small percentage of nitrogen 
remained in the Command Module atmosphere, we 
saw no loss of red cell mass. This poses a 
very interesting and intriguing physiological 
question which remains unanswered to date, 
namely; is it the high oxygen environment 
that causes the loss of red cell mass or is 
it the presence of nitrogen that prevents the 
loss of red cell mass? In addition to the 
above, decreased plasma volumes have been 
consistently observed postflight and are most 
likely associated with the fluid balance 
changes and loss of total body water. We 
have found immunological changes whose magni- 
tude is in keeping with the changes associ- 
ated with those observed in ground-based 
studies and cannot be attributed exclusively 
to space flight. Specifically, we have seen 
changes in immune globulins A and G but these 
increases were associated with pre- and in- 
flight illness and were within the ranges 
associated with such conditions. The increase 
in haptoglobin and ceruloplasmin postflight 
can be attributed to the stresses of reentry, 
splashdown and.recovery.
In addition to the pre- and postflight Hema- 
tology and Immunology Studies, blood will be 
drawn inflight for the first time in the U.S. 
Manned Space Flight Program and will be 
preserved and returned for postflight analysis 
for comparison with the pre- and postflight 
studies (Figure 7)   The information obtained 
will augment the body fluid shift studies, 
supplement the electrolyte investigations and 
provide cross-checks for the metabolic and 
cardiovascular experiments.
CARDIOVASCULAR (Figure 8)
We have consistently observed throughout 
Mercury, Gemini and Apollo, a decreased 
orthostatic tolerance postflight. This is a 
finding which is readily explained by the 
fact that inflight, the cardiovascular system 
does not have to work against a gravitational 
workload represented by a column of blood 
between the feet and heart and between the 
heart and the head. Because there are recep- 
tors or sensors in the cardiovascular system 
called gravi-receptors, they respond to the 
weightless environment resulting in a new 
physiological level of activity as a normal 
adaptative response. The orthostatic
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intolerance observed postflight is a reflec- 
tion of the changes that occur in space and 
are normal for the weightless environment, but 
are not adequate for the 1-G environment 
until a readaptation back to the preflight 
1-G status occurs. In all but Apollo 15, the 
return to preflight values have occurred in 
three to five days.
The assessment of the cardiovascular system 
is accomplished by imposing an externally 
imposed workload or stress on the system. In 
the early days of Mercury and Gemini, we 
used the tilt table as the stressor but with 
subsequent development, the Lower Body Nega- 
tive Pressure Device (LBNP) has been cross- 
calibrated with the tilt table and has been 
used pre- and postflight in Apollo with the 
exception of the quarantine missions (Figure 
9). This device will be used inflight in 
Skylab and its development was specifically 
in anticipation of the inflict ability to 
stresses in the cardiovascular system since 
it is obvious that the tilt table could only 
be used in a gravitational field. By 
applying controlled negative pressure to the 
lower half of the body at 30, HO and 50 mm Hg 
negative pressure, the resultant effect is 
that of providing an external force which 
tends to "pool" the blood in the lower extrem- 
ities, thereby, creating a provocative stress 
on the cardiovascular system. By using the 
vectorcardiogram in conjunction with this 
experiment, we will obtain both changes in 
heart rate and changes if they occur in the 
three dimensional electrical characterization 
of the heart. In addition, blood pressure 
is obtained every 30 seconds during the use 
of the LBNP. This infligit information will 
be of inestimable value not only for the 
determination and understanding of the cardio- 
vascular changes as a time course inflight 
but will contribute to the operational medical 
assessment of the Skylab crew as a function 
of mission duration. This is considered to be 
the earliest observable physiological system 
to change in man since it was observed even 
in the short duration of the Mercury missions. 
However, the changes in the cardiovascular 
system cannot be disassociated from blood 
volume and body fluid changes.
PULMONARY FUNCTION AND ENERGY METABOLISM 
(Figure 10)
There has been, in most instances in Apollo, 
a reduced work capacity postflight compared 
to preflight values. This has usually 
returned to preflight levels in two days and 
is based on the oxygen consumption required 
for a calibrated workload on a bicycle 
ergometer. When it has occurred, it has 
averaged a 25$ reduction from the preflight 
level. It is interesting to note that the
energy expenditure for lunar surface EVA's has 
been less than predicted. In spite of the 
fact that we anticipated a reduced energy 
requirement in the 1/6 G environment and we 
had obtained metabolic data during 1/6 G simu- 
lations, the total expenditure on all lunar 
surface EVA's still fell under the predicted 
values.
In Sky lab, we will use the bicycle ergometer 
and its supporting equipment inflight in the 
same configuration as that used pre- and 
postflight (Figure 11). Inflight, the ergom- 
eter will be used at 25, 50 and 75# of the 
preflight control value. During this experi- 
ment, blood pressure, vectorcardiography and 
metabolic rates will be obtained. This will 
be the first attempt to obtain inflight data 
on pulmonary function (minute volume and vital 
capacity). In addition, this will provide 
a significant increase in the level of 
sophistication in our assessment of work 
capacity during manned space flight.
NEUROFHYSIOLOGICAL FUNCTION - VESTIBULAR AND 
SLEEP (Figure 12)
Although not reported by all the Apollo crew- 
men, many have indicated postflight that 
early in the mission, they experienced what 
has been commonly referred to as "stomach 
awareness." This has usually disappeared 
within the first ^8 hours of the mission with 
no reoccurrence. Interestingly enough, 
Mercury and Gemini were free of any reports 
or instances of this nature including Gemini 
5 and 7 where specific head movements were 
programmed as an experiment to see if any of 
the symptoms of motion sickness could be 
induced. In Apollo, we have had, early in 
the flight program, one or two instances that 
could be termed "motion sickness." In Apollo 
15, we had our one and only instance of a 
postflight vestibular finding. One of the 
crewmen experienced "stomach awareness" during 
trans-lunar coast which disappeared with 
lunar orbit and landing and did not reoccur 
during trans-Earth coast. However, following 
recovery, he experienced what was described 
as a feeling of being about 20-30 degrees 
head-down when lying horizontally in bed. 
This condition completely disappeared after 
about one week.
In the area of sleep, we have mainly subjec- 
tive reporting wherein early in the Gemini 
Program, the attempt to have one man awake 
and on duty while the other one slept proved 
to be disturbing to the one trying to sleep. 
This culminated in the change to both crew- 
men sleeping at the same time to avoid the 
noise and activity which occurred with one 
crewman awake and active % In Gemini T» in- 
flight electroencephalograms were obtained and 
no abnormalities whatsoever' were found on the 
returned records.
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In Sky lab, we will have our first opportunity 
to investigate the question of whether there 
is a threshold shift in sensitivity of the 
vestibular apparatus in weightlessness. This 
will be done by using a rotating chair, elec- 
trically driven, and so designed that all 
rotations of the chair including starting and 
stopping are below the threshold of percep- 
tion in a 1-G environment (Figure 13)  The 
chair will be used in two modes: (l) in the 
dynamic (rotating) mode which will assess the 
sensitivity of the semi-circular canals in 
the weightless environment; and (2) the static 
mode which will assess the sensitivity of the 
otoliths in the weightless environment.
In addition to the above, EEG f s will be 
obtained on one of the crewmen during sleep 
about every other night (15 times in the 28 
day SL-2 mission and 21 times in the $6 day 
SL-3 and k mission) - (Figure 1*0 . This EEC 
is designed with an automatic onboard ana- 
lyzer and associated magnetic tapes for 
storing and returning the data which will 
permit the subsequent analyses of the amount 
of each of the four stages of sleep. Some 
of the fatigue which has been consistently 
observed in the crewmen post flight might 
possibly be associated with changes in sleep 
quality. It is most important to keep in 
mind that there is great individual variabil- 
ity both between individuals and in the same 
individual in the vestibular and sleep areas.
TIME AM) MOTION - BEHAVIORAL (Figure 15)
If you recall in Figure 1, I listed this as 
"Behavioral - Lunar Surface" since we have 
observed no psychological or performance 
changes in our manned space flight activities 
to date. We have looked at data from many 
flight activities such as rendezvous and 
docking, lunar orbit insertion, LEM descent 
and landing and other inflight activities and, 
in each instance, the flight performance can 
be superimposed upon the simulation and 
training data with no significant differences. 
The only area in which we have determined a 
change has been in the translation of the 
training and simulation for EVA from the 1-G 
environment to the 1/6 G on the lunar surface. 
Our studies have indicated that it has taken 
longer in the 1/6 G than we had planned in 
the timeline for many of the lunar surface 
activities. We have also noted that there 
is a rapid learning experience on the lunar 
surface with shortening of the time required 
for certain activities with each subsequent 
EVA.
In Skylab, we will assess the translation of
1-G and water immersion training to the 
actual inflight situation (Figure 16). We 
will use the data acquisition camera to film 
already scheduled activities, primarily experi- 
ments but some operational activities as well.
Postflight analyses of the returned films 
will be compared to films of the same func- 
tions taken during preflight training and 
simulation (Figure 1?)  
jXPERIMENT INTERRELATIONSHIPS (Figure 18)
I am sure it has become evident that as I 
have described these medical experiments that 
they are interrelated and that the results 
of one will have a bearing on another. For 
example, if stomach awareness should occur 
early in the Skylab mission as it has on the 
Apollo flights, this would have an under- 
standable effect on eating. If the intake 
of food and fluid is reduced, then, there 
will be a resultant effect on the nutritional 
and electrolyte data. The electrolyte 
changes can, in turn, effect fluid shifts 
and fluid loss from the body which, in turn, 
would be reflected in the cardiovascular 
system changes. With changes in the cardio- 
vascular system, it would be natural to 
expect a change in exercise response and, of 
course, nutrition is directly related to 
energy metabolism. Any of these foregoing 
features could influence the quality and 
quantity of sleep which could result in 
fatigue and could be reflected in perfor- 
mance changes. The point here is not that 
any or all of these things will occur but 
it establishes the fact that there is this 
close interrelationship in all of these 
experiments and not one of them stands alone 
nor can it be evaluated without complete 
knowledge of the results of the other. A 
very important element of this Skylab Medical 
Experiments Program is the fact that Medical 
Experiment Principal Investigators are 
working together as a team. The medical 
evaluations and decisions will be based on 
the integration by this team of the total 
data analysis process. This insures that no 
isolated data point will be misconstrued and 
insures a cross-check which will preclude 
erroneous judgment.
.SUMMARY
Virtually all of our medical information from 
manned space flights to date has been derived 
from pre- and post flight data or observa- 
tions made by the crewmen and reported at 
the postflight debriefings. Skylab presents 
the first opportunity to investigate in- 
fligiht, the time course of the physiological 
parameters of prime importance to manned 
space flight.
The medical experiments in Skylab are unique 
in that they are not only experiments but
will provide operational and medical informa^ 
tion for mission continuation decisions and 
equally as important; the basis for the go/ 
no go decision for SL-3 after SL-2.
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It is only reasonable to expect that many new 
questions will arise from the Slcylab Medical 
Experiments Program. Conversely, it would 
be overly optimistic to assume that we will 
obtain answers to all the questions concerning 
the observed changes we have seen in manned 
space flights to date. However, the Sky lab 
Medical Experiments Program is a tremendous 
stride forward in that direction* It will be 
an important contribution to the future of 
manned space flight.
AREAS OF MAJOR MEDICAL OBSERVATIONS 
o METABOLISM
o H&4ATOLOGY
O CARDIOVASCULAR
o PULMONARY
o VESTIBULAR
o BEHAVIORAL - LUNAR SURFACE
Figure 1. Areas of Major Medical Observa- 
tions.
NUTRITIONAL AND MUSCULOSKELSTAL FUNCTION
(METABOLISM)
PURPOSE: DETERMINE EXTENT OF SKELETAL AND MUSCULAR 
ALTERATIONS; EVALUATE MINERAL, WATER, 
ELECTROLYTE AND HORMONAL CHANGES; ASSESS 
NUTRITIVE REQUIREMENTS
Figure 2. Metabolism.
Figure k. Waste Management System.
Figure 5. Body Mass Measurement Device.
Figure 3. Small Mass Measurement Device.
HllftTOLOGY' AID PJCTODOGY 
 PURPOSE.: J2KPERMINS SPACE FUG1T EFFECTS ON
PHXSIDLOG? OF FORMED BLOOD ELEMENTS, 
'BODY FUTQ) CGMPAKEMEKPS, AND'
SffilCTED ASPECT S OF IMMUNITY 
Figure 6. Hematology and Immunology.
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Figure ?  Automatic Sample Processor.
CARDIOVASCULAR FUNCTION
PURPOSE: ASSESS EFFECTS OF SPACE FLIOTT 
ON CIRCULATORY SYSTEM 
(HEART AND BLOOD VESSELS) 
Figure 8. Cardiovascular Function.
*******
PULMONARY FUNCTION AND ENERGY METABOLISM
PURPOSE: ASSESS EFFECTS OF SPACECRAFT ENVIRONMENT ON
CREW'S RESPIRATION, BODY MASS AND COMPOSITION, 
AND ENERGY COSTS OF PHYSICAL ACTIVITY
Figure 10. Pulmonary Function and Energy 
Metabolism.
Figure 11. Bicycle Ergoineter and Metabolic 
Analyzer.
Figure 9- Lover Body Negative Pressure 
Device (LBNP).
NEUROFHYSIOLOGECAL FUNCTION 
(VESTIBULAR AND SLEEP)
PURPOSE: EVALUATE EFFECTS OF THE SPACE 
ENVIRONMENT UPON THE CENTRAL 
NERVOUS SYSTEM OF MAI
Figure 12. Neurophysiological Function - 
Vestibular and Sleep.
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Figure 13. Rotating Litter Chair.
TIME AND MOTION 
(BEHAVIORAL)
PURPOSE: ASSESS MAN'S FUNCTIONAL EFFICIENCY IN
COMPLETING OPERATIONAL AND SCIENTIFIC WORK 
DURING LONG DURATION SPACE FLK3KT
Figure 15. Time and Motion - Behavioral.
Figure 16. Orbital Workshop - Work Area.
Figure Ik. Sleep Station.
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TIME AND MOTION STUDY
SKYLAB EXPERIMENT MIS!
16 MM CAMERA WITH 
QUICK UNIVERSAL 
MOUNT
PORTABLE HIGH 
INTENSITY 
PHOTOGRAPHIC 
LAMP
NASA HQ ML71-. 
2-2-71 ACTIVITY TO BE PHOTOGRAPHED
Figure IT. Time and Motion Hardware.
LIFE SCIENCES EXPERIMENT INTERRELATIONSHIPS
TIME AND MOTION STUDY
MINERAL BALANCE ^^'"^'^^ 
BONE DENSITOMETRY / 
BICASSAY OF 8CDY FLUIDS ^ 
SPECIME
Sti.EP MONITORING
N MASS MEASUREMENT / X
CYTCGENETIC STUDIES 
OF BLOOD
MAN'S IMMUNITY IN 
VITRO ASPECTS
BLOOD VOLUME AND RED CELL 
LIFE SPAN
RED BLOOD CELL METABOLISM 
SPECIAL HEMATCLCGlC EFFECT 
SINGLE HUMAN CELL
PULMONARY
AND
ENERGY
METABOLISM
METABOLIC ACTIVITY 
BODY MASS MEASUREMENT
LOWER BODY NEGATIVE PRESSURE 
(PRE- & POST-FLIGHT;
INFLIGHT LOWER BODY 
NEGATIVE PRESSURE
VECTORCARDIOGRAM
HABITABILITY
HABITABILITY,CREW QUARURS
ENVIRONMENT
AEROSOL ANALYSIS 
RADIATION MONITORING
BIO-RHYTHMS
ORCADIAN RHYTHM - POCKET MICE 
ORCADIAN RHYTHM - VINEGAR GNAT
Figure 18. Medical Experiments Interrelation­ 
ships .
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